Trevena Announces Two OLINVYK® Presentations at ANESTHESIOLOGY® 2021

NEXT STORY
Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Specialists (ASRS) Annual Meeting
PREV STORY
TCR² Therapeutics to Host R&D Day on October 20, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Announces Pricing of Public Offering of Common Stock

ALPHARETTA, Ga., March 07, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

author_avatar
NASDAQ Market News

US Department of Defense Research Collaboration Moves Forward

Key Highlights: Three US Defense Health funded research projects on Travelan® successfully completedStudies commissioned ...

author_avatar
NASDAQ Market News

Onxeo Announces 10th Positive DSMB Recommendation to Continue Livatag® ReLive Phase III Trial in HCC

PARIS, May 23, 2017 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Paris:ONXEO) (NASDAQ Copenhagen:ONXEO), a ...

author_avatar
NASDAQ Market News